NYSE: NVS
Novartis Ag Earnings & Revenue

NVS past earnings growth

How has NVS's earnings growth performed historically?
Company
-5.88%%
Industry
10.67%%
Market
48.36%%
NVS's earnings have grown slower (3.99%% per year) than the US Drug Manufacturers - General industry average (8.57%%)
Performance
NVS's earnings have grown slower (3.99%% per year) than the US market average (42.66%%)
Performance
NVS's earnings growth is slowing down - its growth over the last year (-5.88%%) is below its 5-year compound annual rate (3.99%%)
Performance

NVS past revenue growth

How has NVS's revenue growth performed historically?
Company
5.59%%
Industry
6.99%%
Market
14.24%%
NVS's revenue has grown slower (-1.92%% per year) than the US Drug Manufacturers - General industry average (4.11%%)
Performance
NVS's revenue has grown slower (-1.92%% per year) than the US market average (16.09%%)
Performance
NVS's revenue growth is accelerating - its growth over the last year (5.59%%) is above its 5-year compound annual rate (-1.92%%)
Performance

NVS earnings and revenue history

Current Revenue
$48.7B
Current Earnings
$11.7B
Current Profit Margin
24.1%%
NVS's has not demonstrated consistent long-term earnings growth over the past 10 years (38.38%%)
Performance

NVS Return on equity

Current Company
17.5%%
Current Industry
36.3%%
Current Market
14.9%%
NVS's Return on Equity (17.5%%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

NVS Return on assets

Current Company
8.9%%
Current Industry
9.4%%
Current Market
6.9%%
NVS is generating higher Return on Assets (8.9%%) than the US Drug Manufacturers - General industry average (8.19%%)
Performance

NVS Return on capital employed

Current Company
15.95%%
Current Industry
14.4%%
NVS has gotten more efficient at generating Return on Capital (15.95%%) compared to 3 years ago (7.91%%)
Performance

Novartis Ag Earnings & Revenue FAQ

As of Q4 2020, Novartis Ag's earnings has grown -5.88%% year over year. This is 16.55 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 10.67%%. Novartis Ag's earnings in the past year totalled $11.73 billion.
As of Q4 2020, Novartis Ag's revenue has grown 5.59%% year over year. This is 1.4 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 6.99%%. Novartis Ag's revenue in the past year totalled $48.68 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics